26
|
Ye Y, Vattai A, Zhang X, Zhu J, Thaler CJ, Mahner S, Jeschke U, von Schönfeldt V. Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases. Int J Mol Sci 2017; 18:ijms18081651. [PMID: 28758928 PMCID: PMC5578041 DOI: 10.3390/ijms18081651] [Citation(s) in RCA: 53] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2017] [Revised: 07/24/2017] [Accepted: 07/27/2017] [Indexed: 01/13/2023] Open
Abstract
Normal pregnancy is a state of hypercoagulability with diminishing fibrinolytic activity, which is mainly caused by an increase of plasminogen activator inhibitor type 1 (PAI-1). PAI-1 is the main inhibitor of plasminogen activators, including tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). In human placentas, PAI-1 is expressed in extravillous interstitial trophoblasts and vascular trophoblasts. During implantation and placentation, PAI-1 is responsible for inhibiting extra cellular matrix (ECM) degradation, thereby causing an inhibition of trophoblasts invasion. In the present study, we have reviewed the literature of various reproductive diseases where PAI-1 plays a role. PAI-1 levels are increased in patients with recurrent pregnancy losses (RPL), preeclampsia, intrauterine growth restriction (IUGR), gestational diabetes mellitus (GDM) in the previous pregnancy, endometriosis and polycystic ovary syndrome (PCOS). In general, an increased expression of PAI-1 in the blood is associated with an increased risk for infertility and a worse pregnancy outcome. GDM and PCOS are related to the genetic role of the 4G/5G polymorphism of PAI-1. This review provides an overview of the current knowledge of the role of PAI-1 in reproductive diseases. PAI-1 represents a promising monitoring biomarker for reproductive diseases and may be a treatment target in the near future.
Collapse
|
27
|
Mann C, Rogenhofer N, Mahner S, Thaler CJ. [The renaissance of hormonal therapy]. MMW Fortschr Med 2017; 159:39-42. [PMID: 28550548 DOI: 10.1007/s15006-017-9705-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
|
28
|
Rogenhofer N, Markoff A, Wagner A, Klein HG, Petroff D, Schleussner E, Thaler CJ. Möglicher Benefit einer niedermolekularen Heparinisierung in der Schwangerschaft bei habituellen Aborten und M2/Annexin-A5 (ANXA-5) Trägerschaft: post-hoc Analyse der EThiG-II-Studie. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
29
|
Rogenhofer N, Ott J, Schönfeldt VV, Pilatz A, Wolf J, Windischbauer L, Mittenzwei S, Mahner S, Thaler CJ, Steger K. Verminderte Protamin-mRNA Ratio humaner Spermatozoen scheint mit rezidivierenden Aborten assoziiert. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
30
|
Rogenhofer N, Mittenzwei S, Gluderer J, Schönfeldt VV, Mahner S, Thaler CJ. Assoziation von Cholecalciferol (D3) Serumkonzentrationen mit Rahmenaspekten der Assistierten Reproduktionsmedizinischen Therapie (ART). Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
31
|
Rogenhofer N, Nienhaber L, Mittenzwei S, Bogdanova N, Markoff A, Mahner S, Thaler CJ. Paternale M2/Annexin-A5 Trägerschaft als Risikofaktor für IUGR, Präklampsie und Frühgeburtlichkeit. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
32
|
Ye Y, Vogel M, Burger P, Rogenhofer N, Mahner S, Jeschke U, Thaler CJ, Schönfeldt VV. Prurified anti-trophoblast antibodies (ATAB) suppress the secretion of human Chorionic Gonadotropin (hCG) and stimulate that of Plaminogen-Activator-Inhibitor Type 1 (PAI-1) in JEG-3 cells in vitro. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
33
|
Eggersmann TK, Schuster V, Eifert S, Kolben TM, Ueberfuhr P, Zugenmaier B, Kublickiene K, Reichart B, Hagl C, Pichlmaier M, Mahner S, Guethoff S, Thaler CJ. Ascending aortic disease is associated with earlier menopause and shorter reproductive life span. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
34
|
Sela L, Rogenhofer N, Mittenzwei S, Mahner S, Thaler CJ, Schönfeldt VV. Higher pregnancy rate of embryos with synchronous transition from the 2-cell to the 4-cell stage independently of the GnRH analogue used for controlled ovarian stimulation. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
35
|
Franz M, Marschalek J, Ott J, Pavlik R, Watrelot A, Thaler CJ. A comparison of transabdominal versus transvaginal laparoscopic ovarian drilling for polycystic ovary syndrome. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
36
|
Rogenhofer N, Gluderer J, Crispin A, Bond G, Zeisler H, Thaler CJ. Anti-Trophoblast Antikörper (ATAk) sind spezifisch für idiopathische Spontanaborte und nicht mit Antikörpern gegen allogenes HLA assoziiert. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
37
|
Müller-Stoy G, Pavlik R, Alba Alejandre I, Kästner R, Gülberg V, Mahner S, Thaler CJ. Schwere toxische Leberschädigung nach ICSI und nachfolgender Schwangerschaft. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
38
|
von Schönfeldt V, Rogenhofer N, Ruf K, Thaler CJ, Jeschke U. Sera of patients with recurrent miscarriages containing anti-trophoblast antibodies (ATAB) reduce hCG and progesterone production in trophoblast cells in vitro. J Reprod Immunol 2016; 117:52-6. [DOI: 10.1016/j.jri.2016.07.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Revised: 07/12/2016] [Accepted: 07/17/2016] [Indexed: 11/17/2022]
|
39
|
Schuster V, Eggersmann TK, Eifert S, Ueberfuhr P, Zugenmaier B, Kolben TM, Thaler CJ, Kublickiene K, Rieger A, Reichart B, Hagl C, Pichlmaier MA, Guethoff S. Ascending Aortic Disease is Associated with Earlier Menopause and Shorter Reproductive Life Span. J Womens Health (Larchmt) 2016; 25:912-9. [DOI: 10.1089/jwh.2015.5559] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
|
40
|
Rogenhofer N, Markoff A, Wagner A, Klein HG, Petroff D, Schleussner E, Thaler CJ. Lessons From the EThIGII Trial. Clin Appl Thromb Hemost 2016; 23:27-33. [DOI: 10.1177/1076029616658117] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
This study presents sample size considerations derived from the Efficacy of Thromboprophylaxis as an Intervention during Gravidity (EThIGII) trial (ClinicalTrials.gov: NCT00400387) to address the question of low-molecular-weight heparin (LMWH) treatment in women with recurrent pregnancy loss (RPL) depending on the M2/ANXA5 haplotype. To evaluate the possible influence of such treatment on miscarriage rates of trial participants, a post hoc analysis of ANXA5 promoter genotypes in the light of M2/ANXA5 ( RPRGL3) distribution was performed using logistic models. DNA for genotyping was available from 129 LMWH and 95 control patients, 44 (19.6%) of whom were M2/ANXA5 carriers. Miscarriages occurred in 1 (4.0%) of 25 M2/ANXA5 carriers from the LMWH group compared to 4 (21.1%) of 19 in the control group, resulting in an odds ratio (95% confidence interval) for miscarriage of 0.16 (0.016-1.5) for women treated with LMWH. In noncarriers, miscarriage rates were 6 (5.8%) of 104 versus 7 (9.2%) of 76 for the LMWH and the control groups, respectively, corresponding to an odds ratio for miscarriage of 0.60 (0.19-1.9). The apparent beneficial effects of miscarriage rate reduction in M2/ANXA5 carriers with RPL concur with biological considerations about improvement in reduced ANXA5 function through LMWH treatment in an adequate murine model. The data obtained were instrumental to design proper assessment of the existence and magnitude of this effect.
Collapse
|
41
|
Ye Y, Vogel M, Burger P, Thaler CJ, Rogenhofer N, Jeschke U, Mahner S, von Schönfeldt V. Isolated IgGs from sera of recurrent miscarriage (RM) patients with anti-trophoblast antibodies suppress the expression of human Chorionic Gonadotropin (hCG) and stimulated the expression of Plaminogen-Activator-Inhibitor Type 1 (PAI-1) in JEG-3 cells in. J Reprod Immunol 2016. [DOI: 10.1016/j.jri.2016.04.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
42
|
Ye Y, Vogel M, Burger P, Thaler CJ, Rogenhofer N, Jeschke U, Mahner S, von Schönfeldt V. Isolated IgGs from sera of recurrent miscarriage (RM) patients with anti-trophoblast antibodies suppress the expression of human Chorionic Gonadotropin (hCG) and stimulated the expression of Plaminogen-Activator-Inhibitor Type 1 (PAI-1) in JEG-3 cells in. J Reprod Immunol 2016. [DOI: 10.1016/j.jri.2016.04.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
43
|
Heublein S, Hecht S, Nick V, Thaler CJ, Mahner S, Jeschke U, Pavlik R. Regulation der ovariellen Steroidbiosynthese über das Stresshormon CRH am Modell humaner kultivierter Granulosazellen. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1580641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
44
|
Ye Y, Vogel M, Burger P, Thaler CJ, Rogenhofer N, Jeschke U, Mahner S, Schönfeldt VV. Isolated IgGs from sera of recurrent miscarriage (RM) patients with anti-trophoblast antibodies suppress the expression of human Chorionic Gonadotropin (hCG) and stimulated the expression of Plaminogen-Activator-Inhibitor Type 1 (PAI-1) in JEG-3 cells in vitro. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1580647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
45
|
Neusser M, Rogenhofer N, Dürl S, Ochsenkühn R, Trottmann M, Jurinovic V, Steinlein O, von Schönfeldt V, Müller S, Thaler CJ. Increased chromosome 16 disomy rates in human spermatozoa and recurrent spontaneous abortions. Fertil Steril 2015; 104:1130-7.e1-10. [PMID: 26318886 DOI: 10.1016/j.fertnstert.2015.07.1160] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2014] [Revised: 07/25/2015] [Accepted: 07/27/2015] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To investigate if unexplained recurrent spontaneous abortions (RSA) are associated with increased rates of aneuploidy in spermatozoa of RSA partners ("RSA-men"). DESIGN Case-control study. SETTING Academic research center. PATIENT(S) Patients enrolled at the Hormone and Fertility Center and controls at the Department of Urology (LMU-Munich). INTERVENTION(S) Sperm samples of 11 partners of unexplained RSA cases evaluated for elevated diploidy and disomy levels of chromosomes 1-22, X, and Y by multicolor sperm fluorescence in situ hybridization (FISH). MAIN OUTCOME MEASURE(S) Aneuploidy rates obtained in RSA-men compared with controls from the literature and internally; an increase of the aneuploidy rate was considered statistically significant, when it differed ≥ 2 standard deviations from the mean baseline level in controls. RESULT(S) Our sperm FISH data on RSA men showed increased disomy rates for at least three chromosomes in more than 60% of patients but no statistically significant increase of the overall mean sperm disomy or diploidy rate. In particular, meiotic errors involving chromosome 16 contributed to increased sperm disomy in more than 60% of our patients. CONCLUSION(S) These data suggest that among paternal meiotic errors nondisjunction of chromosome 16 might have similar relative influence on fetal aneuploidy compared with maternal chromosome 16 disomy.
Collapse
|
46
|
Thaler CJ. Folate Metabolism and Human Reproduction. Geburtshilfe Frauenheilkd 2014; 74:845-851. [PMID: 25278626 DOI: 10.1055/s-0034-1383058] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2014] [Revised: 08/13/2014] [Accepted: 08/14/2014] [Indexed: 10/24/2022] Open
Abstract
Folate metabolism affects ovarian function, implantation, embryogenesis and the entire process of pregnancy. In addition to its well-established effect on the incidence of neural tube defects, associations have been found between reduced folic acid levels and increased homocysteine concentrations on the one hand, and recurrent spontaneous abortions and other complications of pregnancy on the other. In infertility patients undergoing IVF/ICSI treatment, a clear correlation was found between plasma folate concentrations and the incidence of dichorionic twin pregnancies. In patients supplemented with 0.4 mg/d folic acid undergoing ovarian hyperstimulation and oocyte pick-up, carriers of the MTHFR 677T mutation were found to have lower serum estradiol concentrations at ovulation and fewer oocytes could be retrieved from them. It appears that these negative effects can be compensated for in full by increasing the daily dose of folic acid to at least 0.8 mg. In carriers of the MTHFR 677TT genotype who receive appropriate supplementation, AMH concentrations were found to be significantly increased, which could indicate a compensatory mechanism. AMH concentrations in homozygous carriers of the MTHFR 677TT genotype could even be overestimated, as almost 20 % fewer oocytes are retrieved from these patients per AMH unit compared to MTHFR 677CC wild-type individuals.
Collapse
|
47
|
Rogenhofer N, Mittenzwei S, Schönfeldt VV, Gluderer J, Thaler CJ. Cholecalciferol (D3) Serumkonzentrationen bei IVF/ICSI-Patientinnen. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
48
|
Sela L, Mittenzwei S, Rogenhofer N, Friese K, Thaler CJ, Schönfeldt VV. Nutzen der Time-Lapse Technologie zur Identifizierung von befruchteten Eizellen mit einem zeitlich diskordant auftretenden 3. Vorkern (Pronukleus). Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1387971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
49
|
Schönfeldt VV, Rogenhofer N, Friese K, Thaler CJ, Jeschke U. Anti-Trophoblast-Antikörper (ATAK) im Serum von Patientinnen mit rezidivierenden Spontanaborten (RSA) sind Antikörper gegen Prostaglandin-E-Rezeptor-3 (EP3). Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1387986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
50
|
Hecht S, Heublein S, Pavlik R, Noss U, Vrekoussis T, Jeschke U, Thaler CJ. Auswirkungen des Folatantagonisten Methotrexat auf Apoptose und Steroidmetabolismus humaner primärer Granulosazellen. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|